Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Language
Publication year range
1.
Arch Razi Inst ; 78(6): 1873-1877, 2023 Dec.
Article in English | MEDLINE | ID: mdl-38828180

ABSTRACT

In the present research, we aimed to determine the characteristics of E. faecalis strains collected from an Iranian Children's Hospital for four years. Sixty-seven E. faecalis isolates with virulence genes detection, variable-number tandem repeat (VNTR), and multiple-locus variable-number tandem repeat analysis (MLVA) typing were investigated. A high frequency of virulence genes belonged to gelatinase (73%) and Enterococcus faecalis (62%). The MLVA of 67 E. faecalis isolates revealed 52 VNTR patterns and 38 MLVA types (MTs). Furthermore, genetic diversities with the majority of the MT1 as a major MT in different Wards of the Children's Hospital were found.


Subject(s)
Enterococcus faecalis , Gram-Positive Bacterial Infections , Minisatellite Repeats , Enterococcus faecalis/genetics , Iran , Humans , Gram-Positive Bacterial Infections/veterinary , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/epidemiology , Child , Hospitals, Pediatric , Genetic Variation , Virulence Factors/genetics
2.
Article in English | WPRIM (Western Pacific) | ID: wpr-203145

ABSTRACT

PURPOSE: Staphylococcus aureus is one of the most important causes of nosocomial and community-acquired infections. The increasing incidence of multiple antibiotic-resistant S. aureus strains and the emergence of vancomycin resistant S. aureus strains have placed renewed interest on alternative means of prevention and control of infection. S. aureus produces a variety of virulence factors, so a multi-subunit vaccine will be more successful for preventing S. aureus infections than a mono-subunit vaccine. MATERIALS AND METHODS: We selected three important virulence factors of S. aureus, clumping factor A (ClfA), iron-regulated surface determinant (IsdB), and gamma hemolysin (Hlg) that are potential candidates for vaccine development. We designed synthetic genes encoding the clfA, isdB, and hlg and used bioinformatics tools to predict structure of the synthetic construct and its stabilities. VaxiJen analysis of the protein showed a high antigenicity. Linear and conformational B-cell epitopes were identified. RESULTS: The proteins encoded by these genes were useful as vaccine candidates against S. aureus infections. CONCLUSION: In silico tools are highly suited to study, design, and evaluate vaccine strategies.


Subject(s)
Community-Acquired Infections , Computational Biology , Computer Simulation , Epitopes, B-Lymphocyte , Genes, Synthetic , Incidence , Staphylococcus aureus , Vaccines , Vancomycin , Virulence Factors
3.
Acta Microbiol Immunol Hung ; 57(2): 87-94, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20587382

ABSTRACT

The rapid identification of relevant bacterial pathogens is of utmost importance in clinical settings. The aim of this study was to test a rapid identification technique for A. baumannii strains from Tehran Hospitals and to determine the antibiotic resistance profiles of the isolates. A hundred strains of Acinetobacter spp. grown from clinical specimens were identified as A. baumannii by conventional methods. Using PCR a bla OXA-51 -like gene was detected in all A. baumannii isolates but not in other species of acinetobacter. More than half of the isolates proved resistant to a variety of antibiotics by the disk diffusion technique. The rate of resistance to gentamicin, imipenem, ampicillin-sulbactam and amikacin was determined to be 45%, 53%, 62% and 62%, respectively. Moreover, most isolates (more than 90%) showed resistance to cephalosporins. This study shows that the demonstration of the bla OXA-51-like gene is a reliable and rapid way for the presumptive identification of A. baumannii and reveals that the rate of antibiotic resistance is high in Iranian A. baumannii isolates to a variety of antibiotics.


Subject(s)
Acinetobacter baumannii/isolation & purification , Polymerase Chain Reaction/methods , beta-Lactamases/genetics , Acinetobacter baumannii/drug effects , Drug Resistance, Bacterial
4.
New Microbiol ; 32(3): 265-71, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19845108

ABSTRACT

The MICs of imipenem, meropenem, piperacillin-tazobactam, cefotaxime, polymixin B and tigecycline against 80 isolates of Acintobacter baumanii from 6 hospitals were determined. A multiplex-PCR was used to detect the genes encoding carbapenemases. Field Inversion Gel Electrophoresis (FIGE) was then used to investigate the genetic relationships among the carbapenem-resistant isolates. Only 7 isolates were resistant to polymixin B and tigecycline (MIC = 16). All isolates were positive for at least 2 carbapenemase genes. At least 10 distinct clones were detected by FIGE. A dominant pattern designated as pulsotype A consisting of 23 isolates was detected from 4 hospitals. The majority of isolates in this pulsotype had a bla(OXA-51/23-like) and bla(OXA-51/24-like) carbapenemase genes and cultured from the patients at burns and ICU. The pan drug resistant isolates belonged to different FIGE patterns. Nosocomial infections with different clones of Acintobacter baumanii occur at Tehran hospitals. However, inter-hospital transmission with certain pulsotypes is likely.


Subject(s)
Acinetobacter Infections/microbiology , Acinetobacter baumannii/genetics , Anti-Bacterial Agents/therapeutic use , Carbapenems/therapeutic use , Drug Resistance, Multiple, Bacterial/genetics , Acinetobacter Infections/complications , Acinetobacter Infections/drug therapy , Acinetobacter Infections/epidemiology , Acinetobacter baumannii/drug effects , Acinetobacter baumannii/isolation & purification , Bacterial Proteins/genetics , Cefotaxime/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/etiology , Electrophoresis, Gel, Pulsed-Field , Genes, Bacterial , Hospitals , Humans , Imipenem/therapeutic use , Iran/epidemiology , Meropenem , Penicillanic Acid/analogs & derivatives , Penicillanic Acid/therapeutic use , Piperacillin/therapeutic use , Piperacillin, Tazobactam Drug Combination , Thienamycins/therapeutic use , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...